Challenges of Treating Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
In this video, from AJMCtv, Peter Berger, MD, FACC, FAHA, chairman of cardiology and co-director of the Geisinger Heart & Vascular Institute and director of the Cardiovascular Center for Clinical Research at Geisinger Clinic in Danville, Pennsylvania, discusses the challenge of individualizing antiplatelet treatment for acute coronary syndrome (ACS) patients.

Related Articles
Study finds that black patients who visit the emergency department with ACS have more symptoms and higher symptom severity than white patients.
Starlin Haydon-Greatting, MS, BSPharm, FAPHA, director of clinical programs at the Illinois Pharmacists Association, discusses how pharmacists can become involved in patient-centered medical homes and accountable care organizations.
A recent study examines the comparative efficacy of prasugrel and clopidogrel in the treatment of patients who underwent percutaneous coronary intervention.
Patients who were treated for persistent depression after an acute coronary syndrome experienced improved outcomes during treatment, but worsened outcomes after treatment ended.
Latest Issues
$auto_registration$